Drug intelligence / Profile preview

Lipovax-Fg15-TB

Development stage: Preclinical
Lead developer: Lipotek
Modality: Nanoparticles → Drug Delivery Systems, Vaccines & Immunotherapeutics
Administration: Injection

Overview

Lipovax-Fg15-TB is a preclinical liposome-based vaccine candidate developed by Lipotek for the prevention or treatment of tuberculosis. Utilizing Lipotek's proprietary Lipovax platform, the vaccine is designed to deliver specific tuberculosis antigens, specifically the Fg15 antigen, to elicit a protective immune response against *Mycobacterium tuberculosis*. The Lipovax technology employs liposomes as both a delivery vehicle and an adjuvant system to enhance the presentation of antigens to the immune system. As of 2016, the program was in preclinical development through academic collaborations.

Other names: Lipovax-Fg15-TB-Lipotek-liposome-based vaccine-vaccine-TuberculosisLipovax-Fg-15-TB-Lipotek-liposome-based vaccine-vaccine-TuberculosisLipovax-Fg 15-TB-Lipotek-liposome-based vaccine-vaccine-Tuberculosis

Beyond the preview

Go deeper on Lipovax-Fg15-TB.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipovax-Fg15-TB.

Explore the full profile